MOTS-C is a synthetic 16-amino-acid peptide supplied for controlled laboratory research and analytical evaluation. It corresponds to a mitochondrial-derived peptide sequence encoded within the mitochondrial 12S rRNA region.
Laboratory studies may use MOTS-C to examine peptide identity, mitochondrial-to-nuclear communication markers, gene-expression-associated measurements, and other predefined cellular endpoints. References to mitochondrial signaling, cellular pathways, or stress-condition models describe laboratory research categories only.
These research contexts do not indicate that MOTS-C affects aging, body weight, glucose regulation, exercise capacity, physical performance, neurological function, or any other outcome in humans or animals. Lot-specific analytical documentation is available through the Nordsci Certificate of Analysis Library.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
MOTS-C is a synthetic 16-amino-acid peptide research material supplied as a lyophilized powder for controlled laboratory analysis and in vitro experimentation. Its sequence corresponds to a mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region.
Laboratory studies may use MOTS-C to examine peptide characterization, analytical identity, mitochondrial-associated signaling markers, nuclear gene-expression-associated measurements, and other predefined cellular endpoints.
References to mitochondrial communication, cellular pathway activity, nutrient-associated models, or laboratory stress conditions identify experimental systems only. They do not indicate that MOTS-C improves metabolism, increases energy, reduces body weight, changes glucose regulation, delays aging, or affects physical performance.
MOTS-C Research Peptide Specifications:
| Compound | MOTS-C |
| Unit Size | 5mg or 10mg per vial |
| Unit Quantity | 1 vial |
| Sequence | MRWQEMGYIFYPRKLR |
| Compound Type | Synthetic mitochondrial-derived peptide research material |
| Form | Lyophilized powder |
| Source | Chemical synthesis |
| Molecular Formula / Weight | Refer to the applicable lot-specific analytical documentation |
| Purity / Identity | Refer to the lot-specific Certificate of Analysis |
| Analytical Documentation | Lot-specific documentation may report HPLC, mass spectrometry, or other applicable analytical results |
| Storage Conditions | Store sealed at −20°C or below and protect from light, heat, and moisture unless otherwise stated in the applicable documentation |
| Research Classification | Laboratory research and analytical use only |
| Restrictions | Not for human or animal consumption or in vivo, diagnostic, therapeutic, food, drug, cosmetic, or dietary-supplement use |
MOTS-C is classified as a mitochondrial-derived peptide. Its sequence is associated with an open reading frame located within the mitochondrial 12S rRNA region. Synthetic MOTS-C provides laboratories with a defined material for analytical characterization and controlled cell-based experimentation.
In vitro studies may examine MOTS-C-associated molecular activity using selected cellular systems. Applicable endpoints can include mitochondrial-associated markers, transcription-associated measurements, protein-expression analysis, intracellular localization, or other assay-specific observations.
Researchers may also examine communication between mitochondrial-associated signals and nuclear gene-expression pathways. These studies require clearly defined cell models, controls, concentration ranges, exposure periods, sampling intervals, and analytical methods.
Observed molecular activity remains specific to the selected laboratory system. It does not establish anti-aging, neuroprotective, metabolic, weight-related, glucose-related, exercise-related, or therapeutic effects.
Important Research Notice: Nordsci research materials are supplied with access to lot-specific analytical documentation. Researchers should consult the applicable Certificate of Analysis for reported identity and purity information.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR IN VIVO, DIAGNOSTIC, THERAPEUTIC, FOOD, DRUG, COSMETIC, OR DIETARY-SUPPLEMENT USE.
MOTS-C may be evaluated in controlled cellular systems designed to measure predefined mitochondrial-associated markers. Researchers can compare test conditions with untreated, vehicle, or other suitable controls.
Results remain specific to the selected in vitro system. They should not be interpreted as evidence that MOTS-C improves mitochondrial function or physiological performance.
Laboratory studies may examine selected markers associated with communication between mitochondrial and nuclear systems. Applicable endpoints can include transcription-associated measurements, protein-expression markers, and intracellular localization.
These observations characterize molecular activity within a defined assay. They do not establish effects on aging, longevity, physical ability, cognition, or health.
Researchers may incorporate MOTS-C into cell-based assays designed to measure selected intracellular pathway markers under standardized conditions. Experimental plans should define the target marker, reference controls, sampling intervals, analytical platform, and acceptance criteria.
Activity observed in these models does not demonstrate effects on metabolism, glucose handling, insulin sensitivity, fat mass, body weight, or exercise capacity.
MOTS-C may be evaluated under predefined laboratory conditions involving changes in culture media, nutrient availability, temperature, oxidative conditions, or other controlled variables.
These experiments characterize assay-specific molecular responses. They do not establish protection, resilience, recovery, disease prevention, or physiological adaptation in humans or animals.
MOTS-C should be handled only by qualified laboratory personnel using established procedures for synthetic peptide research materials. Laboratories should document product receipt, lot identification, storage conditions, sample allocation, testing methods, and disposal.
No reconstitution volume, diluent selection, concentration, dosing, injection, administration, or in vivo application guidance is provided.
Quality-Control Considerations:
Lot-specific analytical reports apply only to the tested lot. They should not be interpreted as evidence of clinical safety, effectiveness, therapeutic value, or approval for human or veterinary use.
Nordsci Peptides supplies MOTS-C in 5mg and 10mg vial sizes as a laboratory research material with access to lot-specific analytical documentation. Laboratories should evaluate compound identity, reported analytical results, storage requirements, batch traceability, and institutional procurement standards before use.
IMPORTANT: MOTS-C is sold exclusively for laboratory research and analytical use. It is not a drug, food, dietary supplement, cosmetic, or therapeutic product. It is not approved for human or veterinary use and must not be used for consumption, diagnosis, treatment, prevention, compounding, or any in vivo procedure.
